Total Funding
36
4
Total FundingPost-IPO Equity raised
Growth Score 36 in past quarter
-4 pts
Heat Score 4 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3255051
TUOXIN is a pharmaceutical company that specializes in R&D and production of nucleosides acid.
About the Company
TUOXIN is a high-tech enterprise integrating the R&D, production, and sales of chemical synthesis and biological fermentation of nucleoside pharmaceutical intermediates. They offer nucleoside fermentation technology platforms and biotransformation semi-synthesis technology platforms and products, such as cytosine, 5-fluorocytosine, cytidine,
and other pharmaceutical intermediates.